🇺🇸 FDA
Patent

US 9469664

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

granted A61KA61K31/496A61K31/5377

Quick answer

US patent 9469664 (Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups) held by Sarepta Therapeutics, Inc. expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/496, A61K31/5377, A61P, A61P13/12